$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] PLAG Exerts Anti-Metastatic Effects by Interfering with Neutrophil Elastase/PAR2/EGFR Signaling in A549 Lung Cancer Orthotopic Model 원문보기

Cancers, v.12 no.3, 2020년, pp.560 -   

Kim, Guen Tae (Korea Research Institute of Bioscience and Biotechnology, 125 Kwahak-ro, Daejeon 34141, Korea) ,  Hahn, Kyu Woong (kgt121@kribb.re.kr) ,  Yoon, Sun Young (Department of Biological Sciences, Hannam University, 1646 Daedeok-daero, Daejeon 34054, Korea) ,  Sohn, Ki-Young (ENZYCHEM life sciences, 10F aT Center 27 Gangnam-daero, Seoul 06774, Korea) ,  Kim, Jae Wha (syyoon@enzychem.com (S.Y.Y.))

Abstract AI-Helper 아이콘AI-Helper

The effectiveness of chemotherapy and radiotherapy to treat lung cancer is limited because of highly metastatic nature. Novel strategies and drugs to attenuate metastatic activity are urgently required. In this study, red fluorescence proteins (RFP)-labeled A549 human lung cancer cells were orthotop...

Keyword

참고문헌 (51)

  1. 1. Bray F. Ferlay J. Soerjomataram I. Siegel R.L. Torre L.A. Jemal A. Global cancer statistics 2018: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA A Cancer J. Clin. 2018 68 394 424 10.3322/caac.21492 30207593 

  2. 2. Miller K.D. Siegel R.L. Lin C. Mariotto A.B. Kramer J.L. Rowland J.H. Stein K.D. Alteri R. Jemal A. Cancer treatment and survivorship statistics, 2016 CA A Cancer J. Clin. 2016 66 271 289 10.3322/caac.21349 27253694 

  3. 3. Perez-Tomas R. Multidrug resistance: Retrospect and prospects in anti-cancer drug treatment Curr. Med. Chem. 2006 13 1859 1876 10.2174/092986706777585077 16842198 

  4. 4. Molina J.R. Yang P. Cassivi S.D. Schild S.E. Adjei A.A. Non-small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship Mayo Clin. Proc. 2008 83 584 594 10.1016/S0025-6196(11)60735-0 18452692 

  5. 5. Poullis M. Shackcloth M. Page R. Asanti-Siaw J. Woolley S. Mediratta N. Metastatic index of non-small-cell lung cancer and long-term survival Asian Cardiovasc. Thorac. Ann. 2015 23 185 190 10.1177/0218492314545833 25107893 

  6. 6. Di J.-Z. Peng J.-Y. Wang Z.-G. Prevalence, clinicopathological characteristics, treatment, and prognosis of intestinal metastasis of primary lung cancer: A comprehensive review Surg. Oncol. 2014 23 72 80 10.1016/j.suronc.2014.02.004 24656432 

  7. 7. Milovanovic I. Stjepanovic M. Mitrovic D. Distribution patterns of the metastases of the lung carcinoma in relation to histological type of the primary tumor: An autopsy study Ann. Thorac. Med. 2017 12 191 198 10.4103/atm.ATM_276_16 28808491 

  8. 8. Zhang X. Zhang W. Yuan X. Fu M. Qian H. Xu W. Neutrophils in cancer development and progression: Roles, mechanisms, and implications (review) Int. J. Oncol. 2016 49 857 867 10.3892/ijo.2016.3616 27573431 

  9. 9. Li S. Cong X. Gao H. Lan X. Li Z. Wang W. Song S. Wang Y. Li C. Zhang H. Tumor-associated neutrophils induce emt by il-17a to promote migration and invasion in gastric cancer cells J. Exp. Clin. Cancer Res. 2019 38 6 10.1186/s13046-018-1003-0 30616627 

  10. 10. Kim Y. Lee D. Lee J. Lee S. Lawler S. Role of tumor-associated neutrophils in regulation of tumor growth in lung cancer development: A mathematical model PLoS ONE 2019 14 1 e0211041 10.1371/journal.pone.0211041 30689655 

  11. 11. Lerman I. de la Garcia-Hernandez M. Rangel-Moreno J. Chiriboga L. Pan C. Nastiuk K.L. Krolewski J.J. Sen A. Hammes S.R. Infiltrating myeloid cells exert protumorigenic actions via neutrophil elastase Mol. Cancer Res. 2017 15 1138 1152 10.1158/1541-7786.MCR-17-0003 28512253 

  12. 12. Moroy G. Alix A.J.P. Sapi J. Hornebeck W. Bourguet E. Neutrophil elastase as a target in lung cancer Anti Cancer Agents Med. Chem. 2012 12 565 579 10.2174/187152012800617696 22263788 

  13. 13. Feliciano P. Cxcl1 and cxcl2 link metastasis and chemoresistance Nat. Genet. 2012 44 10.1038/ng.2379 

  14. 14. Li L. Xu L. Yan J. Zhen Z.-J. Ji Y. Liu C.-Q. Lau W. Zheng L. Xu J. Cxcr2?cxcl1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma J. Exp. Clin. Cancer Res. 2015 34 129 10.1186/s13046-015-0247-1 26503598 

  15. 15. Shi H. Han X. Sun Y. Shang C. Wei M. Ba X. Zeng X. Chemokine (c-x-c motif) ligand 1 and cxcl2 produced by tumor promote the generation of monocytic myeloid-derived suppressor cells Cancer Sci. 2018 109 3826 3839 10.1111/cas.13809 30259595 

  16. 16. Hjortoe G.M. Petersen L.C. Albrektsen T. Sorensen B.B. Norby P.L. Mandal S.K. Pendurthi U.R. Rao V.L. Tissue factor-factor viia?specific up-regulation of il-8 expression in mda-mb-231 cells is mediated by par-2 and results in increased cell migration Blood 2004 103 3029 3037 10.1182/blood-2003-10-3417 15070680 

  17. 17. Fan Z. Li Y. Zhao Q. Fan L. Tan B. Zuo J. Hua K. Ji Q. Highly expressed granulocyte colony-stimulating factor (g-csf) and granulocyte colony-stimulating factor receptor (g-csfr) in human gastric cancer leads to poor survival Med Sci. Monit. Int. Med. J. Exp. Clin. Res. 2018 24 1701 1711 10.12659/MSM.909128 

  18. 18. Kawano M. Mabuchi S. Matsumoto Y. Sasano T. Takahashi R. Kuroda H. Kozasa K. Hashimoto K. Isobe A. Sawada K. The significance of g-csf expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer Sci. Rep. 2015 5 18217 10.1038/srep18217 26666576 

  19. 19. Albrengues J. Shields M.A. Ng D. Park C. Ambrico A. Poindexter M.E. Upadhyay P. Uyeminami D.L. Pommier A. Kuttner V. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice Science 2018 361 eaao4227 10.1126/science.aao4227 30262472 

  20. 20. Wculek S.K. Malanchi I. Neutrophils support lung colonization of metastasis-initiating breast cancer cells Nature 2015 528 413 10.1038/nature16140 26649828 

  21. 21. Garcia-Mendoza M.G. Inman D.R. Ponik S.M. Jeffery J.J. Sheerar D.S. Doorn R.R. Keely P.J. Neutrophils drive accelerated tumor progression in the collagen-dense mammary tumor microenvironment Breast Cancer Res. 2016 18 49 10.1186/s13058-016-0703-7 27169366 

  22. 22. Bergin D.A. Greene C.M. Sterchi E.E. Kenna C. Geraghty P. Belaaouaj A. Belaaouaj A. Taggart C.C. O’Neill S.J. McElvaney N.G. Activation of the epidermal growth factor receptor (egfr) by a novel metalloprotease pathway J. Biol. Chem. 2008 283 31736 31744 10.1074/jbc.M803732200 18772136 

  23. 23. Darmoul D. Gratio V. Devaud H. Laburthe M. Protease-activated receptor 2 in colon cancer trypsin-induced mapk phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation J. Biol. Chem. 2004 279 20927 20934 10.1074/jbc.M401430200 15010475 

  24. 24. De Almeida V. dos Guimaraes I. Almendra L.R. Rondon A. Tilli T.M. de Melo A.C. Sternberg C. Monteiro R.Q. Positive crosstalk between egfr and the tf-par2 pathway mediates resistance to cisplatin and poor survival in cervical cancer Oncotarget 2018 9 30594 30609 10.18632/oncotarget.25748 30093972 

  25. 25. Olayan A. Hussaini H. Jazieh A. The roles of epidermal growth factor receptor (egfr) inhibitors in the management of lung cancer J. Infect. Public Health 2012 5 1054 1062 10.1016/j.jiph.2012.09.004 23244189 

  26. 26. Prabhakar C.N. Epidermal growth factor receptor in non-small cell lung cancer Transl. Lung Cancer Res. 2015 4 110 118 25870793 

  27. 27. Sharma S.V. Bell D.W. Settleman J. Haber D.A. Epidermal growth factor receptor mutations in lung cancer Nat. Rev. Cancer 2007 7 169 181 10.1038/nrc2088 17318210 

  28. 28. Weng C.-H. Chen L.-Y. Lin Y.-C. Shih J.-Y. Lin Y.-C. Tseng R.-Y. Chiu A.-C. Yeh Y.-H. Liu C. Lin Y.-T. Epithelial-mesenchymal transition (emt) beyond egfr mutations per se is a common mechanism for acquired resistance to egfr tki Oncogene 2019 38 455 468 10.1038/s41388-018-0454-2 30111817 

  29. 29. Poh M.-E. Liam C.-K. Rajadurai P. Chai C.-S. Epithelial-to-mesenchymal transition (emt) causing acquired resistance to afatinib in a patient with epidermal growth factor receptor (egfr)-mutant lung adenocarcinoma J. Thorac. Dis. 2018 10 E560 E563 10.21037/jtd.2018.06.122 30174934 

  30. 30. George A.J. Hannan R.D. Thomas W.G. Unravelling the molecular complexity of gpcr-mediated egfr transactivation using functional genomics approaches FEBS J. 2013 280 5258 5268 10.1111/febs.12509 23992425 

  31. 31. Wang Z. Transactivation of epidermal growth factor receptor by g protein-coupled receptors: Recent progress, challenges and future research Int. J. Mol. Sci. 2016 17 95 10.3390/ijms17010095 26771606 

  32. 32. Yang H. Kim S. Cho S.-H. Kim M.-G. Seo J.-Y. Park J.-S. Jhon G.-J. Han S.-Y. Purification and structural determination of hematopoietic stem cell-stimulating monoacetyldiglycerides from cervus nippon (deer antler) Chem. Pharm. Bull. 2004 52 874 878 10.1248/cpb.52.874 15256714 

  33. 33. Jeong J. Kim Y.-J. Lee D. Moon B.-G. Sohn K.-Y. Yoon S. Kim J. 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (plag) attenuates gemcitabine-induced neutrophil extravasation Cell Biosci. 2019 9 4 10.1186/s13578-018-0266-7 30622698 

  34. 34. Lee H.-R. Yoo N. Kim J. Sohn K.-Y. Kim H.-J. Kim M.-H. Han M. Yoon S. Kim J. The therapeutic effect of plag against oral mucositis in hamster and mouse model Front. Oncol. 2016 6 209 10.1159/000444393 27800302 

  35. 35. Kim Y.-J. Shin J. Shin S.-H. Kim J. Sohn K.-Y. Kim H.-J. Kang J.-K. Yoon S. Kim J. 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol ameliorates arthritic joints through reducing neutrophil infiltration mediated by il-6/stat3 and mip-2 activation Oncotarget 2014 5 96636 96648 10.18632/oncotarget.19384 29228558 

  36. 36. Powell D.R. Huttenlocher A. Neutrophils in the tumor microenvironment Trends Immunol. 2016 37 41 52 10.1016/j.it.2015.11.008 26700397 

  37. 37. Cools-Lartigue J. Spicer J. Najmeh S. Ferri L. Neutrophil extracellular traps in cancer progression Cell. Mol. Life Sci. 2014 71 4179 4194 10.1007/s00018-014-1683-3 25070012 

  38. 38. Friedl P. Wolf K. Tumour-cell invasion and migration: Diversity and escape mechanisms Nat. Rev. Cancer 2003 3 362 374 10.1038/nrc1075 12724734 

  39. 39. DeFea K.A. Zalevsky J. Thoma M.S. Dery O. Mullins R.D. Bunnett N.W. B-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated erk1/2 J. Cell Biol. 2000 148 1267 1282 10.1083/jcb.148.6.1267 10725339 

  40. 40. Gieseler F. Ungefroren H. Settmacher U. Hollenberg M.D. Kaufmann R. Proteinase-activated receptors (pars)―focus on receptor-receptor-interactions and their physiological and pathophysiological impact Cell Commun. Signal. 2013 11 86 10.1186/1478-811X-11-86 24215724 

  41. 41. Young S.G. Davies B.S.J. Fong L.G. Gin P. Weinstein M.M. Bensadoun A. Beigneux A.P. Gpihbp1: an endothelial cell molecule important for the lipolytic processing of chylomicrons Curr. Opin. Lipidol. 2007 18 389 396 17620854 

  42. 42. Puca L. Chastagner P. Meas-Yedid V. Israel A. Brou C. A-arrestin 1 (arrdc1) and β-arrestins cooperate to mediate notch degradation in mammals J. Cell Sci. 2013 126 4457 4468 10.1242/jcs.130500 23886940 

  43. 43. Hinshaw D.C. Shevde L.A. The tumor microenvironment innately modulates cancer progression Cancer Res. 2019 10.1158/0008-5472.CAN-18-3962 

  44. 44. Yuan M. Zhu H. Xu J. Zheng Y. Cao X. Liu Q. Tumor-derived cxcl1 promotes lung cancer growth via recruitment of tumor-associated neutrophils J. Immunol. Res. 2016 2016 6530410 10.1155/2016/6530410 27446967 

  45. 45. Liubomirski Y. Lerrer S. Meshel T. Rubinstein-Achiasaf L. Morein D. Wiemann S. Korner C. Ben-Baruch A. Tumor-stroma-inflammation networks promote pro-metastatic chemokines and aggressiveness characteristics in triple-negative breast cancer Front. Immunol. 2019 10 757 10.3389/fimmu.2019.00757 31031757 

  46. 46. Neutrophils help circulating tumor cells metastasize Cancer Discov. 2019 9 458 459 

  47. 47. Szczerba B. Castro-Giner F. Vetter M. Krol I. Gkountela S. Landin J. Scheidmann M.C. Donato C. Scherrer R. Singer J. Neutrophils escort circulating tumour cells to enable cell cycle progression Nature 2019 566 553 557 10.1038/s41586-019-0915-y 30728496 

  48. 48. Zhuo C. Wu X. Li J. Hu D. Jian J. Chen C. Zheng X. Yang C. Chemokine (c-x-c motif) ligand 1 (cxcl1) is associated with tumor progression and poor prognosis in patients with colorectal cancer Biosci. Rep. 2018 38 

  49. 49. Acharyya S. Oskarsson T. Vanharanta S. Malladi S. Kim J. Morris P.G. Manova-Todorova K. Leversha M. Hogg N. Seshan V.E. A cxcl1 paracrine network links cancer chemoresistance and metastasis Cell 2012 150 165 178 10.1016/j.cell.2012.04.042 22770218 

  50. 50. Pawar N.R. Buzza M.S. Antalis T.M. Membrane-anchored serine proteases and protease-activated receptor-2?mediated signaling: Co-conspirators in cancer progression Cancer Res. 2019 79 301 310 10.1158/0008-5472.CAN-18-1745 30610085 

  51. 51. Lerman I. Ma X. Seger C. Maolake A. de la Garcia-Hernandez M. Rangel-Moreno J. Ackerman J. Nastiuk K.L. Susiarjo M. Hammes S.R. Epigenetic suppression of serpinb1 promotes inflammation-mediated prostate cancer progression Mol. Cancer Res. 2019 17 845 859 10.1158/1541-7786.MCR-18-0638 30610107 

LOADING...

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로